Disease groups
2,194 disease groups, by OMIA group number.
| OMIA group | Name | Species | The chain reached | Best score |
|---|---|---|---|---|
| 1310 | Clench | 1 | Animal disease only | |
| 1311 | Photoreceptor dysplasia, PPT1-related | 1 | Target evidence | 58.4 |
| 1314 | Retinal atrophy - Rod-cone dysplasia 3, PDE6A-related | 1 | Drug | 61.3 |
| 1315 | Osteochondrodysplasia | 2 | Human disease | 12.0 |
| 1317 | Mucopolysaccharidosis II | 2 | Human disease | 37.0 |
| 1318 | Elliptocytosis, SPTB-related | 1 | Human gene | 34.0 |
| 1319 | Myopathy of the diaphragmatic muscles | 1 | Animal disease only | |
| 1323 | Dwarfism, GHR-related | 3 | Human disease | 34.0 |
| 1324 | Melanoblastoma | 1 | Animal disease only | |
| 1325 | Protein-losing enteropathy | 1 | Human disease | 6.5 |
| 1326 | Protein-losing nephropathy | 1 | Human disease | 9.0 |
| 1327 | Hyperkeratosis, palmoplantar, FAM83G-related | 1 | Animal disease only | |
| 1330 | Linear IgA disease | 1 | Animal disease only | |
| 1331 | Eclampsia | 1 | Human disease | 9.0 |
| 1333 | Persistent right oviduct | 1 | Animal disease only | |
| 1334 | Sperm, short tail | 3 | Human gene | 35.0 |
| 1335 | Renal cystadenocarcinoma and nodular dermatofibrosis, FLCN-related | 1 | Target evidence | 57.1 |
| 1339 | Von Willebrand disease II | 2 | Drug | 63.4 |
| 1340 | Complex vertebral malformation | 3 | Target evidence | 62.1 |
| 1341 | Night blindness, congenital stationary, TRPM1-related | 1 | Human disease | 14.0 |
| 1342 | Mucopolysaccharidosis IIIB | 4 | Target evidence | 65.4 |
| 1345 | Tricuspid valve dysplasia | 2 | Human disease | 12.0 |
| 1346 | Retinal atrophy, progressive, autosomal dominant, RHO-related | 3 | Target evidence | 50.7 |
| 1348 | Atrichia with papular lesions | 1 | Target evidence | 54.9 |
| 1349 | Urolith, KMgP | 2 | Animal disease only | |
| 1351 | Neuromuscular disease, degenerative | 1 | Animal disease only | |
| 1352 | Visual impairment | 1 | Animal disease only | |
| 1353 | Scott syndrome | 1 | Target evidence | 59.0 |
| 1356 | Coat colour, grey/gray | 3 | Animal disease only | |
| 1360 | Trimethylaminuria (fishy taint) | 4 | Human gene | 40.0 |
| 1361 | Dysplasia epiphysealis hememelica | 1 | Human disease | 9.0 |
| 1363 | Ataxia, progressive, with head tremor and seizures | 1 | Animal disease only | |
| 1364 | Fused labia | 1 | Animal disease only | |
| 1365 | Achromatopsia-3, CNGB3-related | 2 | Target evidence | 62.6 |
| 1366 | Retinal dysplasia and degeneration | 1 | Target evidence | 53.4 |
| 1367 | Blindness enlarged globe | 1 | Animal disease only | |
| 1368 | Retinopathy globe enlarged | 1 | Target evidence | 51.5 |
| 1369 | Follicular dysplasia and interface dermatitis | 1 | Animal disease only | |
| 1370 | Acrochordonous plaque | 1 | Animal disease only | |
| 1371 | L-2-hydroxyglutaricacidemia | 2 | Target evidence | 65.8 |
| 1372 | Slick hair | 2 | Animal disease only | |
| 1373 | Nasal parakeratosis | 1 | Animal disease only | |
| 1374 | Centronuclear myopathy, HACD1-related | 1 | Target evidence | 51.0 |
| 1400 | Chondrodysplasia, SLC13A1-related | 2 | Animal disease only | |
| 1401 | Waardenburg syndrome, type 2A | 3 | Target evidence | 60.1 |
| 1402 | Multidrug resistance 1, ABCB1-related | 5 | Animal disease only | |
| 1403 | Pancreatitis, hereditary | 2 | Target evidence | 55.2 |
| 1406 | Pyruvate dehydrogenase deficiency | 1 | Target evidence | 61.2 |
| 1407 | Lipofuscinosis | 2 | Animal disease only | |
| 1408 | Guttural pouch tympany | 1 | Animal disease only |